Science Explorer Back to mapMap
Discussion
Researcher · University of Hong Kong · China

John Man Tak Chu

John Man Tak Chu publishes mostly in Molecular Biology, Developmental Neuroscience and Critical Care and Intensive Care Medicine, on topics such as Anesthesia and Neurotoxicity Research, Intensive Care Unit Cognitive Disorders and Neuroinflammation and Neurodegeneration Mechanisms.

ORCID 0000-0003-2377-1054 OpenAlex
World rank
#2,020,744
of 7,710,434 ranked researchers
Rank in China
#311,254
of 978,568
Works
29
Citations
1.2k
Citations per work
39.8
h-index
16
i10-index 17Top 46% in Molecular Biology
John Man Tak Chu

What does John Man Tak Chu research?

John Man Tak Chu's work is mostly in Neuroscience (28%), Biochemistry, Genetics and Molecular Biology (15%), Medicine (11%).

Life Sciences: 14 works · 49.5% of their workNeuroscience: 8 works · 28.3% of their workDevelopmental Neuroscience: 3 works · 11.8% of their workNeurology: 3 works · 9.4% of their workCellular and Molecular Neuroscience: 2 works · 7.1% of their workBiochemistry, Genetics and Molecular Biology: 4 works · 15.3% of their workMolecular Biology: 4 works · 15.3% of their workImmunology and Microbiology: 2 works · 5.9% of their workImmunology: 2 works · 5.9% of their workEverything else: 12 works · 39.9% of their workHealth Sciences: 3 works · 10.6% of their workMedicine: 3 works · 10.6% of their workCritical Care and Intensive Care Medicine: 3 works · 10.6% of their workTHEIR WORKJohn Man Tak Chu29works
Life Sciences49%Health Sciences11%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Neuroscience828.3%
    2. Biochemistry, Genetics and Molecular Biology415.3%
    3. Immunology and Microbiology25.9%
  2. Everything else1239.9%
    1. Medicine310.6%
  1. 1Molecular Biology15% of their works
  2. 2Developmental Neuroscience12% of their works
  3. 3Critical Care and Intensive Care Medicine11% of their works
  4. 4Neurology9% of their works
  5. 5Cellular and Molecular Neuroscience7% of their works
  6. 6Immunology6% of their works

Research topics

Which keywords describe John Man Tak Chu's research?

The keywords of their largest research topics: Brain Development, Synaptic Plasticity, Innate Immunity, Anesthesia, Delirium, Intensive Care Unit, Neurotoxicity and Microglia.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 19 words, with their numbers
  1. Brain Development152 topics
  2. Synaptic Plasticity122 topics
  3. Innate Immunity112 topics
  4. Anesthesia91 topic
  5. Delirium91 topic
  6. Intensive Care Unit91 topic
  7. Neurotoxicity91 topic
  8. Microglia61 topic
  9. Neuroinflammation61 topic
  10. Molecular Chaperones51 topic
  11. Protein Folding51 topic
  12. Molecular Docking41 topic
  13. Virtual Screening41 topic
  14. GABAergic31 topic
  15. Neurotransmission31 topic
  16. Advanced Glycation End Products21 topic
  17. Crystal Structure21 topic
  18. G-Protein-Coupled Receptors21 topic
  19. HMGB121 topic

Where does John Man Tak Chu work?

John Man Tak Chu's main affiliation in the publication record is University of Hong Kong, China.

How many publications and citations does John Man Tak Chu have?

OpenAlex counts 29 works and 1,153 citations for John Man Tak Chu, an h-index of 16, ranking #2,020,744 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about John Man Tak Chu. Posts are plain text and can be reported.